The company added that it has entered into an agreement with Hubei Biocause Heilen Pharmaceutical Co., Limited., Joint Venture Partner for sale of 33,000,000 equity shares of 1 RMB each fully paid-up held by the Company in Granules-Biocause Pharmaceutical Co. Limited for a consideration of RMB 109mn.
from India Infoline News Service https://ift.tt/2LZCylf
No comments:
Post a Comment